Passive ventricular constraint

Progress in Biophysics and Molecular Biology

Volumn 82, Issue 1-3, 2003, Pages 197-206

  Power, John M ^a   Byrne, Melissa ^a   Raman, Jai ^b   Alferness, Clif ^c  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Acorn Cardiovascular Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0037547114     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0079-6107(03)00016-6     Document Type: Conference Paper

References (52)

1. Akhmedov S.D., Krivoschekov E.V.et al. Clinical results of dynamic cardiomyoplasty. J. Cardiovasc. Surg. 10(5):1995;573-579.
2. Alexander J.S., Elrod J.W. Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation. J. Anat. 200(6):2002;561-574.
3. Bansch D., Antz M.et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy. the cardiomyopathy trial (CAT) Circulation. 105(12):2002;1453-1458.
4. Bowles N.E., Bowles K.R.et al. The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz. 25(3):2000;168-175.
5. Buckberg G.D., Coghlan H.C.et al. The structure and function of the helical heart and its buttress wrapping. V. Anatomic and physiologic considerations in the healthy and failing heart. Semin. Thorac. Cardiovasc. Surg. 13(4):2001;358-385.
6. Buckberg G.D., Coghlan H.C.et al. The structure and function of the helical heart and its buttress wrapping. VI. Geometric concepts of heart failure and use for structural correction. Semin. Thorac. Cardiovasc. Surg. 13(4):2001;386-401.
7. Calaghan S.C., White E. The role of calcium in the response of cardiac muscle to stretch. Prog. Biophys. Mol. Biol. 71(1):1999;59-90.
8. Capouya, E.R., Gerber, R.S., et al., 1993. Girdling effect of nonstimulated cardiomyoplasty on left ventricular function. Ann. Thorac. Surg. 56(4), 867-870 (discussion 870-1).
9. Chachques J.C., Mitz V.et al. Experimental cardioplasty using the latissimus dorsi muscle flap. J. Cardiovasc. Surg. (Torino). 26(5):1985;457-462.
10. Chachques J.C., Grandjean P.A.et al. Dynamic cardiomyoplasty. a new approach to assist chronic myocardial failure Life Support Systems. 5(4):1987;323-327.
11. Chaudhry P.A., Mishima T.et al. Passive epicardial containment prevents ventricular remodeling in heart failure. Ann. Thorac. Surg. 70(4):2000;1275-1280.
12. Chaudhry P.A., Anagnostopouls P.V.et al. Acute ventricular reduction with the acorn cardiac support device. effect on progressive left ventricular dysfunction and dilation in dogs with chronic heart failure J. Cardiovasc. Surg. 16(2):2001;118-126.
13. Codd M.B., Sugrue D.D.et al. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation. 80(3):1989;564-572.
14. De Angelis K., Leirner A.A.et al. Nonstimulated cardiomyoplasty improves hemodynamics in myocardial-infarcted rats. Artif. Organs. 25(11):2001;939-943.
15. Evans S.J., Dalton G.R.et al. Experimental studies on myocardial stretch and ventricular arrhythmia in hypertrophied and non-hypertrophied hearts. J. Cardiovasc. Risk. 7(3):2000;163-175.
16. Felker G.M., Hu W., Hare J.M.et al. The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine (Baltimore). 78(4):1999;270-283.
17. Goldfine H., Aurigemma G.P.et al. Left ventricular length-force-shortening relations before and after surgical correction of chronic mitral regurgitation. J. Am. Coll. Cardiol. 31(1):1998;180-185.
18. Grunig E., Tasman J.A.et al. Frequency and phenotypes of familial dilated cardiomyopathy. J. Am. Coll. Cardiol. 31(1):1998;186-194.
19. Henein M.Y., Rakhit R.D.et al. Restrictive pericarditis. Heart. 82(3):1999;389-392.
20. Junker A., Thayssen P.et al. The hemodynamic and prognostic significance of echo-Doppler-proven mitral regurgitation in patients with dilated cardiomyopathy. Cardiology. 83(1-2):1993;14-20.
21. Kashem A., Santamore W.P.et al. CardioClasp. a new passive device to reshape cardiac enlargement Asaio J. 48(3):2002;253-259.
22. Kass D.A., Baughman K.L.et al. Reverse remodeling from cardiomyoplasty in human heart failure. External constraint versus active assist. Circulation. 91(9):1995;2314-2318.
23. Kohl P., Cooper P.J., Holloway H. Effects of acute ventricular volume manipulation on in situ cardiomyocyte cell membrane configuration. Prog. Biophys. Mol. Biol. 82:2003;221-227.
24. Konertz W., Dushe S.et al. Safety and feasibility of a cardiac support device. J. Cardiovasc. Surg. 16(2):2001;113-117.
25. Konertz W.F., Shapland J.E.et al. Passive containment and reverse remodeling by a novel textile cardiac support device. Circulation. 104(12):2001(Suppl. 1), I270-I275.
26. Kono T., Sabbah H.N.et al. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J. Am. Coll. Cardiol. 20(7):1992;1594-1598.
27. Leier C.V. Cardiomyoplasty. is it time to wrap it up? J. Am. Coll. Cardiol. 28(5):1996;1181-1182.
28. Link M.S. Mechanically induced sudden death in chest wall impact (commotio cordis). Prog. Biophys. Mol. Biol. 82:2003;175-186.
29. Malhotra R., Sadoshima J.et al. Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes in vitro. Circ. Res. 85(2):1999;137-146.
30. Martinac B., Kloda A. Evolutionary origins of mechanosensitive ion channels. Prog. Biophys. Mol. Biol. 82:2003;11-24.
31. McClure S.J., Caruana L.et al. Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care. Br. Med. J. 317(7157):1998;516-519.
32. Monnet E. Adynamic cardiomyoplasty. effect on cardiac efficiency and contractile reserve in dogs with adriamycin-induced cardiomyopathy J. Card. Surg. 17(1):2002;60-69.
33. Mott, B.D., J.H. Oh, et al., 1998. Mechanisms of cardiomyoplasty: comparative effects of adynamic versus dynamic cardiomyoplasty. Ann. Thorac. Surg. 65 (4), 1039-1044.
34. Oh J.H., Badhwar V.et al. The effects of prosthetic cardiac binding and a dynamic cardiomyoplasty in a model of dilated cardiomyopathy. J. Thorac. Cardiovasc. Surg. 116(1):1998;148-153.
35. Pilla J.J., Brockman D.J.et al. Ventricular constraint using the acorn cardiac support device (CSD) limits infarct expansion in an ovine model of acute myocardial infarction. J. Cardiac. Fail. 7(Suppl. 2):2001;40.
36. Pilla, J.J., Brockman, D.J., et al., 2001b. Prevention of dilatation using the Acorn cardiac support device (CSD) results in reversed remodeling and improvement of function. Circulation 104 (Suppl. II), II-440.
37. Power J.M., Raman J.et al. Passive ventricular constraint amends the course of heart failure. a study in an ovine model of dilated cardiomyopathy Cardiovasc. Res. 44(3):1999;549-555.
38. Raman J.S., Hata M.et al. The mid-term results of ventricular containment (ACORN WRAP) for end-stage ischemic cardiomyopathy. Ann. Thorac. Cardiovasc. Surg. 7(5):2001;278-281.
39. Riemer T.L., Sobie E.A.et al. Stretch-induced changes in arrhythmogenesis and excitability in experimentally based heart cell models. Am. J. Physiol. 275(2):1998(Part 2), H431-H442.
40. Saavedra W.F., Tunin R.S.et al. Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure. J. Am. Coll. Cardiol. 39(12):2002;2069-2076.
41. Sabbah H.N., Maltsev V.A.et al. Contractile function of cardiomyocytes isolated from dogs with heart failure is enhanced after chronic therapy with passive ventricular constraint using the acorn support device. Circulation. 100(Suppl.):1999;439.
42. Sabbah, H.N., Gupta, R.C., et al., 2001a. Prevention of progressive left ventricular dilatation with the acorn cardiac support device normalizes protein phosphatase activity in dogs with chronic heart failure. Circulation 104(Suppl. II), II-556.
43. Sabbah H.N., Gupta R.C.et al. Prevention of progressive left ventricular dilatation with the Acorn support device downregularlates stretch-responsive proteins and improves sarcoplasmic reticulum recycling in dogs with chronic heart failure. J. Am. Coll. Cardiol. 37(Suppl. A):2001;474A.
44. Sabbah H.N., Kleber F.X.et al. Efficacy trends of the acorn cardiac support device in patients with heart failure. a one year follow-up J. Heart Lung Transplant. 20(2):2001;217.
45. Sabbah H.N., Sharov V.G.et al. Chronic therapy with the acorn cardiac support device in dogs with chronic heart failure. three and six months hemodynamic, histologic and ultrastructural findings J. Heart Lung Transplant. 20(2):2001;189.
46. Schenk S., Reichenspurner H.et al. Myosplint implant and shape-change procedure. intra-and peri-operative safety and feasibility J. Heart Lung Transplant. 21(6):2002;680-686.
47. Stacy G.P. Jr., Jobe R.L.et al. Stretch-induced depolarizations as a trigger of arrhythmias in isolated canine left ventricles. Am. J. Physiol. 263(2):1992(Part 2), H613-H621.
48. Stewart S., MacIntyre K.et al. More malignant than cancer? Five-year survival following a first admission for heart failure. Eur. J. Heart Fail. 3(3):2001;315-322.
49. Sugrue D.D., Rodeheffer R.J.et al. The clinical course of idiopathic dilated cardiomyopathy. A population-based study. Ann. Int. Med. 117(2):1992;117-123.
50. Takagaki M., McCarthy P.M.et al. Novel device to change left ventricular shape for heart failure treatment. device design and implantation procedure Asaio J. 47(3):2001;244-248.
51. Timek T.A., Dagum P.et al. Pathogenesis of mitral regurgitation in tachycardia-induced cardiomyopathy. Circulation. 104(12):2001(Suppl. 1), I47-I53.
52. Wang Z., Taylor L.K.et al. Initiation of ventricular extrasystoles by myocardial stretch in chronically dilated and failing canine left ventricle. Circulation. 90(4):1994;2022-2031.